These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 3363498)
1. [Effectiveness of combined administration of obsidan and sidnofarm in patients with ischemic heart disease at a polyclinic]. Borisov AV Ter Arkh; 1988; 60(1):126-8. PubMed ID: 3363498 [TBL] [Abstract][Full Text] [Related]
2. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease]. Ciopor M; Fischer A; Turina J; Hess OM Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502 [TBL] [Abstract][Full Text] [Related]
3. [Characteristics of patients with ischemic heart disease under dispensary observation in a regional polyclinic and the evaluation of anti-angina therapy conducted under dispensary conditions]. Bekhbudova DA; Kokurina EV; Ostrovskaia TP; Bochkareva EV; Urumbaev RK Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):95-100. PubMed ID: 3924078 [TBL] [Abstract][Full Text] [Related]
4. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders]. Witchitz S; Kolsky H; Moisson P; Valette H Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971 [TBL] [Abstract][Full Text] [Related]
5. [New drug forms of molsidomine, Corvaton-forte and Corvaton-retard, and their antianginal efficacy in stenocardia patients]. Kukushkin SK; Shamarin VM; Manoshkina EM; Berzak NV; Petrosian KIu Ter Arkh; 1996; 68(1):29-30. PubMed ID: 8644025 [No Abstract] [Full Text] [Related]
6. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris. Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171 [TBL] [Abstract][Full Text] [Related]
7. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration]. Hug J; Hasenfuss G; Wollschläger H; Just HJ; Bonzel T Med Klin (Munich); 1994 Jul; 89 Suppl 2():34-7. PubMed ID: 7968899 [No Abstract] [Full Text] [Related]
8. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris]. Butina EK; Kokurina EV; Dmitrieva NA; Bochkareva EV Ter Arkh; 2002; 74(9):36-41. PubMed ID: 12418118 [TBL] [Abstract][Full Text] [Related]
9. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris]. Beloev I; Tomov I; Elenkova A; Terzieva L Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552 [TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of propranolol in an acute test and a course of treatment in patients with stenocardia]. Savvateev KL; Desiatnichenko VM; Romakov AIu; Mazur NA Ter Arkh; 1988; 60(2):96-101. PubMed ID: 3368872 [TBL] [Abstract][Full Text] [Related]
11. [Beta-blockers in effort angina]. Witchitz S; Kolsky H; Moisson P; Philippe B Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():87-95. PubMed ID: 6134513 [No Abstract] [Full Text] [Related]
12. [Effectiveness of drug therapy alone or its combination with plasmapheresis in patients with severe angina pectoris]. Sokolov AV; Kel'man EB; Perepech NB; Tsaí NV Klin Med (Mosk); 1997; 75(8):31-3. PubMed ID: 9340434 [TBL] [Abstract][Full Text] [Related]
14. [Problems in selecting the optimal propranolol dose in treating patients with angina pectoris of effort and the comparative effectiveness of inderal, anaprilin and obzidan]. Romakov AIu; Mazur NA Ter Arkh; 1984; 56(9):41-6. PubMed ID: 6515546 [TBL] [Abstract][Full Text] [Related]